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Abstract
White matter hyperintensities (WMH) constitute the visible spectrum of cerebral small vessel
disease (SVD) markers and are associated with cognitive decline, although they do not fully
account for memory decline observed in individuals with SVD. We hypothesize that WMH
might exert their effect on memory decline indirectly by affecting remote brain structures such
as the hippocampus. We investigated the temporal interactions between WMH, hippocampal
atrophy and memory decline in older adults with SVD. Five hundred and three participants of
the RUNDMC study underwent neuroimaging and cognitive assessments up to 3 times over
8.7 years. We assessed WMH volumes semi-automatically and calculated hippocampal volumes
(HV) using FreeSurfer. We used linear mixed effects models and causal mediation analyses to
assess both interaction and mediation effects of hippocampal atrophy in the associations
between WMH and memory decline, separately for working memory (WM) and episodic mem-
ory (EM). Linear mixed effect models revealed that the interaction between WMH and hippo-
campal volumes explained memory decline (WM: β = .067; 95%CI[.024–0.111]; p < .01; EM:
β = .061; 95%CI[.025–.098]; p < .01), with better model fit when the WMH*HV interaction
term was added to the model, for both WM (likelihood ratio test, χ2[1] = 9.3, p < .01) and for
EM (likelihood ratio test, χ2[1] = 10.7, p < .01). Mediation models showed that both baseline
WMH volume (β = −.170; p = .001) and hippocampal atrophy (β = 0.126; p = .009) were inde-
pendently related to EM decline, but the effect of baseline WMH on EM decline was not medi-
ated by hippocampal atrophy (p value indirect effect: 0.572). Memory decline in elderly with
SVD was best explained by the interaction of WMH and hippocampal volumes. The relationship
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between WMH and memory was not causally mediated by hippocampal atrophy, suggesting that
memory decline during aging is a heterogeneous condition in which different pathologies con-
tribute to the memory decline observed in elderly with SVD.
KEYWORDS
cerebral small vessel disease, cognitive decline, hippocampal volume, neuroimaging, working and
episodic memory
1 | INTRODUCTION
White matter hyperintensities (WMH) are frequently observed on
neuroimaging in older adults (de Leeuw et al., 2001) and constitute an
important radiological marker of cerebral small vessel disease (SVD)
(Wardlaw et al., 2013). WMH have been associated with cognitive
deficits in virtually every domain, including working memory
(WM) and episodic memory (EM) (Debette & Markus, 2010; Prins &
Scheltens, 2015). WM relies on prefrontal and parietal cortical regions
that are largely affected in SVD (Baddeley, 2012; Metoki et al., 2017).
The role of WMH in EM deficits, however, is less well understood, as
EM performance is mainly supported by structures in the medial tem-
poral lobes and especially the hippocampus (Rolls, 2000; Squire &
Zola-Morgan, 1991), which are typically unaffected by WMH
(Lambert et al., 2016).
Several studies have reported associations between WMH and
hippocampal volumes (de Leeuw, Barkhof, & Scheltens, 2004; den
Heijer et al., 2012; Eckerstrom et al., 2011; Fiford et al., 2017; van der
Flier et al., 2005; Ye et al., 2015) and have found a cumulative effect
of WMH and hippocampal atrophy on the degree of cognitive perfor-
mance (Godin et al., 2010; Prins & Scheltens, 2015; van der Flier et al.,
2005), while others have reported that these pathologies are indepen-
dent processes that both affect cognition adversely (Oosterman, Oos-
terveld, Rikkert, Claassen, & Kessels, 2012; Vemuri et al., 2015). Thus
far, studies have not thoroughly investigated the interactions of
WMH, hippocampal atrophy and memory decline longitudinally. This
is especially important as age is an important risk factor for all of these
three phenomena and WMH progresses exponentially over time (van
Leijsen et al., 2017).
There is increasing awareness that SVD exerts its clinical effects
by affecting remote brain structures (Duering et al., 2012; Lambert
et al., 2016), suggesting that disruptions in white matter connections
due to WMH might lead to secondary hippocampal atrophy and a
concomitant memory decline in patients with SVD. A recent cross-
sectional neuroimaging study in patients with Alzheimer's disease
(AD) showed that WMH contributed indirectly to memory deficits by
contributing to temporal lobe atrophy (Swardfager et al., 2018). Pro-
spective studies, however, would be required to elaborate on the
directionality of the associations.
In this article, we specifically examined the temporal interactions
between WMH and hippocampal atrophy for these two memory sys-
tems longitudinally, using three neuroimaging and cognitive assess-
ments over 9 years in an SVD cohort. Specifically, we tested two
hypotheses as to how WMH and hippocampal atrophy might affect
memory decline (Figure 1). First, we tested whether WMH and hippo-
campal atrophy interacted in predicting memory deficits. Second, we
tested whether the effect of WMH on memory decline was mediated
by hippocampal atrophy.
2 | METHODS
2.1 | Study population
This study is part of the RUN DMC study, a prospective cohort study
among 503 nondemented older adults with SVD, aged between
50 and 85 years, that investigates risk factors and clinical conse-
quences of SVD. Symptoms of SVD include both acute symptoms,
such as transient ischemic attack (TIA) or lacunar syndromes, and sub-
acute manifestations such as cognitive and motor (gait) disturbances
(Roman, Erkinjuntti, Wallin, Pantoni, & Chui, 2002). As the onset of
SVD is often insidious, clinically heterogeneous, and typically with
mild symptoms, the selection of participants with SVD was based on
neuroimaging characteristics, including WMH and lacunes (Erkinjuntti,
2002). The detailed study protocol has been published previously (van
Norden et al., 2011). In short, 503 independently living older adults
with SVD, without dementia, were included for baseline assessment
in 2006. Inclusion criteria were age between 50 and 85 years and
presence of SVD on neuroimaging (i.e., WMH and/or lacunes). Subse-
quently, the above mentioned acute and subacute clinical symptoms
of SVD were assessed. Of these 503 participants, 361 underwent
repeated MRI assessment at first follow-up in 2011, and 296 partici-
pants at second follow-up in 2015 (van Leijsen et al., 2017). Of those,
seven participants were excluded because of insufficient scan quality
at baseline, 15 participants at first follow-up, and seven at second
follow-up, yielding a sample of 496 participants for neuroimaging ana-
lyses at baseline, 346 at first follow-up, and 289 at second follow-up.
Thus, in total 1,131 observations could be used for linear mixed effect
analyses. In total, 263 participants underwent repeated cognitive and
neuroimaging assessments of sufficient quality at all three time-points
and could be used for longitudinal analyses (Supporting Information
Figure S1). The Medical Review Ethics Committee region Arnhem-
Nijmegen approved the study and all participants gave written
informed consent.
2.2 | Cognitive function
Cognitive performance was measured using an extensive neuropsy-
chological test battery during all three waves of data collection (van
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Uden et al., 2015). In the present study, we used the immediate and
delayed recall of the Rey Auditory Verbal Learning Test (RAVLT) (Van
der Elst, van Boxtel, van Breukelen, & Jolles, 2005) and Rey Complex
Figure Task (RCFT) (Caffarra, Vezzadini, Dieci, Zonato, & Venneri,
2002) as well as Speed–Accuracy Trade-Off (SAT) scores of the
2-letter and 3-letter subtasks of the Paper–Pencil Memory Scanning
Task (PPMST) (Van Der Elst, Van Boxtel, Van Breukelen, & Jolles,
2007). To account for possible learning effects, parallel versions of the
RAVLT and RCFT were used for the second follow-up assessment.
Performance across tests was made comparable by transforming the
raw test scores into z-scores, where higher z-scores indicate better
performance. Raw scores of all three time-points were transformed
into z-scores based on the mean and standard deviation (SD) of the
baseline study population. We subsequently calculated compound
scores for WM and EM. WM is a compound score of the SAT scores
of the 2-letter and 3-letter subtasks of the PPMST (Van Der Elst et al.,
2007). EM is a compound score of the mean of the z-scores of the
three learning trials and the delayed recall of the RAVLT and the mean
of the z-scores of the immediate recall trial and the delayed recall trial
of the RCFT. Cognitive decline over time was calculated for each par-
ticipant individually, by subtracting baseline scores from the follow-up
scores.
2.3 | Vascular risk factors
We assessed the presence of hypertension, smoking, alcohol use,
body mass index, diabetes, and hypercholesterolemia using standard-
ized questionnaires, as described previously (van Norden et al., 2011).
Hypertension was defined as the use of antihypertensive agents
and/or systolic blood pressure greater than or equal to 140 mmHg
and/or diastolic blood pressure greater than or equal to 90 mmHg.
Diabetes was defined as treatment with diabetic medication and
hypercholesterolemia as the use of lipid-lowering drugs (van Norden
et al., 2011).
2.4 | Neuroimaging protocols
MR images were acquired at three time-points on 1.5-Tesla MRI
(2006: Siemens, Magnetom Sonata; 2011 and 2015: Siemens,
Magnetom Avanto) and included the following whole brain scans:
T1-weighted 3D MPRAGE sequence (isotropic voxel size 1.0 mm3), a
FLAIR sequence (2006: voxel size 0.5 × 0.5 × 5.0 mm, interslice gap
1.0 mm; 2011 and 2015: voxel size 0.5 × 0.5 × 2.5 mm; interslice gap
0.5 mm) and a DTI sequence (2006: isotropic voxel size 2.5 mm3,
4 unweighted scans, 30 diffusion weighted scans at b = 900 s/mm2;
2011 and 2015: isotropic voxel size 2.5 mm3, 8 unweighted scans,
60 diffusion weighted scans at b = 900 s/mm2). Full acquisition details
have been described previously (van Leijsen et al., 2017; van Leijsen
et al., 2018; van Norden et al., 2011) and can be found in the Support-
ing Information Methods.
2.5 | Brain volumetry
We assessed grey matter (GMV), white matter (WMV), and CSF vol-
umes using SPM12 (http://www.fil.ion.ucl.ac.uk/spm/) unified seg-
mentation routines on the T1 MPRAGE images corrected for WMH,
as has been described in detail elsewhere (van Leijsen et al., 2017).
2.6 | White matter hyperintensities
WMH volumes were calculated by a semi-automatic WMH segmenta-
tion method, which has been described previously (Ghafoorian et al.,
2016). Segmentations were visually checked for segmentation errors
by one trained rater, blinded for clinical data. WMH volumes were
corrected for inter-scan-differences in ICV and then normalized to
baseline ICV. We calculated individual annualized WMH progression
rates using linear mixed effects (LME) models based on all available
time-points. The individual WMH progression rates were extracted
and used for further analyses.
2.7 | Hippocampal volumes
Hippocampal volume segmentations were automatically processed
with the longitudinal stream (Reuter, Schmansky, Rosas, & Fischl,
2012) in FreeSurfer 5.3 (http://surfer.nmr.mgh.harvard.edu/). In short,
the T1-weighted images from all three time-points were first pro-
cessed separately using the standard processing stream. Subse-
quently, an unbiased within-subject template was created from all
time-points for each subject using the longitudinal processing stream,
I. Interaction II. Mediation
WMH Memory decline
Hippocampal 
atrophy
WMH
Memory
HV
WMH*HV
FIGURE 1 Illustration of the tested hypotheses. We tested two hypotheses on how white matter hyperintensities and hippocampal atrophy
might affect memory decline: I. WMH and hippocampal atrophy interact in predicting memory decline; II. The effect of WMH on memory decline
is mediated via hippocampal atrophy [Color figure can be viewed at wileyonlinelibrary.com]
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and several processing steps were then initialized with common infor-
mation from the within-subject template, to increase the reliability of
the segmentation of brain regions over time (Reuter et al., 2012). For
those participants who were only able to complete one or two neuro-
imaging assessments, we ran the same longitudinal pipeline using the
available T1-weighted images, to ensure that all images underwent
the same processing steps (Bernal-Rusiel et al., 2013). All segmenta-
tions were visually checked for segmentation accuracy at each time-
point and manually adjusted when necessary. We used LME models
to estimate individual annualized hippocampal atrophy rates based on
all available time-points, with negative values reflecting more hippo-
campal atrophy. The individual hippocampal atrophy rates were
extracted and used for further analyses.
2.8 | Statistical analysis
Change in WMH, HV and cognitive performance over time was tested
using repeated measures ANOVA. We visualized the change in both
working memory and episodic memory over time according to quar-
tiles of baseline WMH and hippocampal volumes. We analyzed WMH
and hippocampal volumes in quartiles of their distribution and tested
continuous linear trend per stratum. We additionally displayed the
change in working and episodic memory according to the interaction
between WMH and hippocampal volumes. We therefore identified
low WMH volume (WMH+), high WMH volume (WMH-), high hippo-
campal volume (HV+), and low hippocampal volume (HV-) based on
median split of baseline volumes, thereby creating four groups: WMH
+/HV+, WMH-/HV+, WMH+/HV-, and WMH-/HV-. Differences
between these groups were calculated using one way ANOVA with
post hoc Bonferroni-correction.
All statistical analyses were carried out in R 3.4.2 (https://www.r-
project.org/). To test whether WMH and hippocampal volumes inter-
acted in predicting memory deficits (Figure 1 – Hypothesis I), we fitted
linear mixed effects (LME) models with memory performance as the
dependent variable using “lme4” version 1.1–14 in R (Bates, Machler,
Bolker, & Walker, 2015). All analyses were performed separately for
working and episodic memory. LME models allow for the simulta-
neous modeling of fixed (population-average) and random (subject-
specific) effects, allowing us to examine memory decline in the entire
population while accounting for individual differences in rates of
memory decline. We fitted four models: (1) a null model including
baseline age, sex and the level of education at baseline. Time between
baseline and follow-up assessments was added as a fixed effect and a
subject-specific random intercept and slope, such that the fixed effect
coefficient estimates group-level memory decline per year, while the
random terms are the individual trajectories of memory decline over
time. In addition, we included a quadratic term for time, as WMH
were found to progress nonlinearly over time (van Leijsen et al.,
2017). In the second model (2), we additionally added WMH volumes
of all available time-points and the interaction between WMH and
time-squared, indicating the effect of nonlinear WMH progression on
memory decline. In the third model (3), we added hippocampal vol-
umes of all available time-points and the interaction between HV and
linear time to the null model, to estimate the effect of hippocampal
atrophy over time on memory decline. (4) In the fully specified model
we additionally added an interaction term between WMH and
HV. We compared model fit between the four models using a likeli-
hood ratio test, and we evaluated the change in Akaike information
criterion (AIC) and Bayesian information criterion (BIC). For both
indexes, smaller values indicate better fit.
We performed additional analyses on the temporal interactions
between WMH, HV, and memory decline. For this, we first used LME
models to estimate individual annualized WMH progression and hip-
pocampal atrophy rates based on all available time-points. The individ-
ual WMH progression and hippocampal atrophy rates were extracted
and used for further analyses. Using “lavaan” version 0.5–23.1097 in
R (Rosseel, 2012), we estimated the effects of baseline WMH volume,
WMH progression, baseline hippocampal volume and hippocampal
atrophy on memory decline, separately for working and episodic
memory decline. We also tested the effect of the interaction term
between baseline WMH and hippocampal volumes on memory
decline. Analyses were adjusted for baseline age, sex and level of edu-
cation at baseline. We compared model fit between the models with
and without the interaction term using a likelihood ratio test.
To test whether interactions between WMH and HV in pre-
dicting memory deficits were specifically attributed to hippocam-
pal atrophy, we performed the same analyses with global gray
matter atrophy instead of hippocampal atrophy. Hence, we com-
pared four models: in the first model (1), we added WMH and
the interaction between WMH and quadratic time only. In the
second model (2), we additionally added HV, the interaction
between HV and time, and the interaction term between WMH
and HV. In the third model (3), we added GMV, the interaction
TABLE 1 Baseline characteristics
Study population (n = 503)
Demographics
Age, years 65.7  8.8
Male sex, number of participants 284 (56.5)
MMSE score 28.1  1.6
Education, years 9.8  1.8
Vascular risk factors
Hypertension, number
of participants
369 (73.4)
Hypercholesterolemia,
number of participants
237 (47.1)
Diabetes, number of participants 75 (14.9)
Smoking, ever, number
of participants
353 (70.2)
Alcohol, glasses/week 7.9  9.3
Body mass index, kg/m2 27.1  4.1
Imaging characteristics
Total brain volume, ml 1,060.9  80.1
Grey matter volume, ml 606.2  52.6
White matter volume, ml 454.7  46.0
Microbleeds, number of participants 83 (16.5)
Lacunes, number of participants 132 (26.2)
WMH volume, ml 3.6 (1.2–11.4)
Hippocampus volume, ml 7.6  1.0
Data represent number of participants (%), mean  SD or median (IQR).
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between GMV and time, and an interaction term between WMH
and GMV to the first model, to estimate the effect of global gray
matter atrophy on memory decline. We additionally fitted a
fourth model (4), in which we added both HV and GMV together
with their interaction terms, to estimate the relative strengths of
hippocampal and global gray matter atrophy in explaining memory
decline.
To test whether hippocampal atrophy mediated the association
between WMH and memory decline (Figure 1, Hypothesis II), we per-
formed mediation analyses using “lavaan” version 0.5–23.1097 in R
(Rosseel, 2012). For this, we first used LME models to estimate indi-
vidual annualized hippocampal atrophy rates based on all available
time-points. The individual hippocampal atrophy rates were extracted
and used for further analyses. Using lavaan, we estimated the direct
FIGURE 2 Age-related working and episodic memory performance by white matter hyperintensities and hippocampal volumes. (a) Spaghetti
plots showing the trajectories of working memory performance (left) and episodic memory performance (right) over time. (b) Age-related working
memory performance by white matter hyperintensities (left) and hippocampal volumes (right). (c) Age-related episodic memory performance by
white matter hyperintensities (left) and hippocampal volumes (right). Dots are color-coded by age, with baseline age of participants ranging from
50 years in light blue to 85 years in dark blue [Color figure can be viewed at wileyonlinelibrary.com]
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effect of baseline WMH volume on memory decline and the indirect
effect of baseline WMH volume on memory decline via hippocampal
atrophy, separately for working and episodic memory decline.
3 | RESULTS
Baseline characteristics of the study population are presented in Table 1.
Mean age at baseline was 65.7 (SD 8.8) years and 57% of the participants
were male. WMH and hippocampal volumes and cognitive performance
over time is shown in Supporting Information Table S1. Higher WMH
volumes were related to both lower WM and lower EM performance
(WM: β = −.295; 95%CI [−.348 - -0.241]; p < .001; EM: β = −.271; 95%
CI [−.324 - -0.217]; p < .001) and higher hippocampal volumes were
related to both higher WM and higher EM performance (WM: β = 0.307;
95%CI [0.253–0.359]; p < .001; EM: β = 0.392; 95%CI [0.341–0.440];
p < .001), modified by age (Figure 2). Change in both working memory
and episodic memory over time according to quartiles of baseline WMH
and hippocampal volumes as well as their interaction was graphically dis-
played in Figure 3. We observed more decline in the WMH-/HV- group
compared to both WMH-/HV+ and WMH+/HV- groups.
3.1 | Memory decline explained by interactions
between WMH and hippocampal atrophy
The results of the mixed effect models are shown in Table 2. Both
models with WMH only and HV only provided significantly better fits
in comparison to the null model, for both WM (WMH only vs. null
model: likelihood ratio test, χ2(2) = 7.3, p < .05; HV only vs. null
model: χ2(2) = 9.8, p < .01) and for EM (WMH only vs. null model:
χ2(2) = 28.3, p < .001; HV only vs. null model: χ2(2) = 74.4, p < .001).
The models with HV alone fitted better than the models with WMH
alone, not only for EM (likelihood ratio test, χ2[0] = 46.1, p < .001),
but also for WM (likelihood ratio test, χ2[0] = 2.4, p < .001). Impor-
tantly, including the WMH*HV interaction term significantly improved
the model, for both WM (likelihood ratio test model with both
WMH & HV vs. full model with WMH*HV interaction term,
χ2[1] = 9.3, p < .01) and for EM (likelihood ratio test model with both
WMH & HV vs. full model with WMH*HV interaction term,,
χ2[1] = 10.7, p < .01). The WMH*HV interaction term was signifi-
cantly associated with memory function (WM: β = .067; 95%CI
[.024–0.111]; p < .01; EM: β = .061; 95%CI [.025–.098]; p < .01).
More hippocampal atrophy was associated with lower EM perfor-
mance (β = .017; 95%CI [.009–.025]; p < .001).
The results of the interaction analyses on decline in WM and EM
are shown in Figure 4. Lower baseline hippocampal volumes
(β = 0.132; p < .001) and higher baseline WMH volumes (β = −.164;
p < .001) were associated with more EM decline. More hippocampal
atrophy was associated with more EM decline (β = 0.120; p < .001).
Including the WMH*HV interaction term significantly improved the
model, for both WM (likelihood ratio test, χ2(1) = 6.0, p < .05) and EM
(likelihood ratio test, χ2(1) = 10.1, p < .01).
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FIGURE 3 Graphical displays of working memory and episodic memory over time according to baseline WMH and hippocampal volumes and
their interaction. Decline in working memory (top) and episodic memory (bottom), according to quartiles of baseline WMH volumes and quartiles
of baseline hippocampal volumes. Right: Decline in working and episodic memory according to the interaction between WMH and hippocampal
volumes. Based on median split of baseline WMH volume (low WMH volume (WMH+) and high WMH volume (WMH-)) and baseline
hippocampal volume (high hippocampal volume (HV+) and low hippocampal volume (HV-)), we identified 4 groups: WMH+/HV+, WMH-/HV+,
WMH+/HV-, and WMH-/HV-. Bars represent decline in z-scores and whiskers represent standard errors. p Trends for continuous linear trend
per stratum are displayed in the corners. *** p < .001; ** p < .01; * p < .05
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Additional analyses on global gray matter atrophy revealed a signifi-
cant interaction effect of WMH*GMV for WM (β = .090; 95%CI
[.004–0.177]; p < .05), though the addition of both hippocampal and gray
matter atrophy to the model rendered the WMH*GMV interaction term
nonsignificant (β = .027; 95%CI [−.077–0.131]; p > .05) where the
WMH*HV interaction term remained significant (β = .059; 95%CI
[.007–0.111]; p < .05). There was no significant interaction effect of
WMH*GMV for EM (β = .073; 95%CI [−.001–0.147]; p > .05).
3.2 | Mediation of the associations between WMH
and memory decline by hippocampal atrophy
The results of the causal mediation analyses are shown in Figure 5,
separately for WM and EM decline. Decline in WM performance over
time was not associated with baseline WMH volume (β = −.022;
p = .707) or hippocampal atrophy (β = .056; p = .306) after adjusting
for age, sex and education. The direct effects of both baseline WMH
volume (β = −.170; p = .001) and hippocampal atrophy (β = 0.126;
p = .009) on EM decline were significantly different from zero. The
effect of baseline WMH on EM decline was not mediated by hippo-
campal atrophy (p value indirect effect: 0.572).
4 | DISCUSSION
We observed that memory decline in individuals with SVD was best
explained by an interaction of WMH and hippocampal atrophy, rather
than these two variables independently. In addition, we showed that
the association between WMH and episodic memory decline was not
causally mediated by hippocampal atrophy. Finally, we demonstrated
WMH
Working memory 
declineWMH*HV
HV
WMH
Episodic memory 
declineWMH*HV
HV
Baseline hippocampal volume:
β=0.051 (p=0.200)
Hippocampal atrophy:
β=0.026 (p=0.481)
β=0.113
(p=0.009)
Hippocampal atrophy:
β=0.120 (p<0.001)
Baseline hippocampal volume:
β=0.132 (p<0.001)
β=0.124
(p=0.001)
Baseline WMH volume:
β=-0.050 (p=0.350)
WMH progression:
β=-0.009 (p=0.848)
Baseline WMH volume:
β=-0.164 (p<0.001)
WMH progression:
β=-0.030 (p=0.469)
FIGURE 4 Diagrams showing interaction analyses explaining memory decline by the interaction of WMH and hippocampal volumes. The
diagrams present standardized estimates (with p values) for all associations, separately for working memory decline (left) and episodic memory
decline (right). The statistical significance of the WMH*HV interaction is presented in the center of the diagram. Analyses were performed using
Lavaan, adjusted for age, sex, education, and baseline memory performance [Color figure can be viewed at wileyonlinelibrary.com]
Baseline WMH
Working memory
decline
Hippocampal atrophy
Direct: p=0.519
Indirect: p=0.725 
-0.022
(p=0.707)
0.056
(p=0.306)
-0.038
(p=0.519)
Baseline WMH
Episodic memory
decline
Hippocampal atrophy
Direct: p=0.001
Indirect: p=0.572 
-0.034
(p=0.563)
0.126
(p=0.009)
-0.170
(p=0.001)
FIGURE 5 Diagrams showing statistical mediation analyses of the relationship between WMH and memory decline by hippocampal atrophy. The
diagrams present standardized estimates (with p values) for all direct associations, separately for working memory (left) and episodic memory
(right). The statistical significance of the direct and indirect paths is presented in the center of the diagram. Analyses were performed using
Lavaan, adjusted for age, sex, and education. The direct effects of both WMH and hippocampal atrophy on episodic memory decline are
significantly different from zero, though the indirect effect of WMH on episodic memory decline via hippocampal atrophy is not, suggesting that
the effect of WMH on episodic memory decline is not causally mediated by hippocampal atrophy [Color figure can be viewed at
wileyonlinelibrary.com]
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that these effects were specific to hippocampal atrophy, rather than
general grey matter atrophy. Together, our findings suggest that mem-
ory decline in patients with SVD is a heterogeneous condition to
which different pathologies contribute.
Our findings that memory decline could be best explained by the
interaction of WMH and hippocampal atrophy are consistent with
imaging studies showing an additive effect of WMH and hippocampal
atrophy on the level of cognitive decline (Godin et al., 2010; Prins &
Scheltens, 2015; van der Flier et al., 2005), although there are also
studies that have reported that AD and vascular pathologies are inde-
pendent processes (Vemuri et al., 2015). These variable findings might
be due to differences in the relative proportion of cerebrovascular
and AD pathologies, with both pathologies being present in many
older adults with dementia (Neuropathology Group of the Medical
Research Council Cognitive Function and Ageing Study, 2001). Our
study adds to these findings by describing the temporal interactions
between both pathologies and memory decline longitudinally, over a
long follow-up of almost 9 years. We found that memory decline
could be best explained by the interaction of WMH and hippocampal
atrophy and that the associations between WMH and hippocampal
atrophy were not causally mediated by hippocampal atrophy, suggest-
ing that WMH and hippocampal atrophy synergistically affect memory
decline. Moreover, we found that this effect of hippocampal atrophy
was not just the result of global brain atrophy, as the effect of hippo-
campal atrophy was stronger than the effect of global gray matter
atrophy.
Interestingly, we observed an interaction between WMH and hip-
pocampal atrophy for WM, although the relative involvement of the
hippocampus itself was lower for WM performance than for EM per-
formance. While it has been argued that WM processing should not
rely on the hippocampus (Baddeley, 2012; Squire & Zola-Morgan,
1991), and we hypothesized that WM performance would be related
to WMH specifically, some degree of long-term encoding has been
demonstrated during WM tasks related to the specific task demands
(Bergmann, Rijpkema, Fernandez, & Kessels, 2012). That is, WM tasks
are rarely “process pure,” but may also include components that pro-
mote incidental long-term encoding (e.g., maintaining the target items
in the PPMT over a longer period of time).
Several mechanisms might be proposed for the association
between WMH and memory decline. WMH might exert their clinical
effects in a direct way by disconnecting white matter tracts, or indi-
rectly through incident stroke (Vermeer et al., 2003) or by affecting
remote brain structures (Duering et al., 2012; Lambert et al., 2016).
Alternatively, vascular risk factors might lead to cognitive decline in
patients with SVD through other mechanisms, such as inflammatory
responses, hormonal dysregulation, or damage to neurotransmitter
systems (Kimura et al., 2000; Roman & Kalaria, 2006; Strachan, Reyn-
olds, Marioni, & Price, 2011). Finally, memory decline in patients with
SVD might also be explained by the interaction of SVD pathology with
other neurodegenerative pathologies, such as seen in AD (Breteler,
2000; Kalaria, 2002; Neuropathology Group of the Medical Research
Council Cognitive Function and Ageing Study, 2001; Prins & Schel-
tens, 2015). Our observations that WMH and hippocampal atrophy
interact in explaining memory decline in patients with SVD support
this hypothesis. This is in line with a study in patients with AD showed
that reduced network integrity was associated with SVD severity, spe-
cifically in networks important for cognition (Nestor et al., 2017). Ani-
mal studies have suggested that neurovascular dysfunction could
potentiate the production of amyloid beta (Koncz & Sachdev, 2018),
suggesting that cerebrovascular pathology might be a risk factor for
AD, although longitudinal evidence on the directionality of associa-
tions between vascular and Alzheimer's pathology in humans remains
limited.
The presence of an interaction effect in the absence of a causal
mediation effect suggests that WMH and hippocampal atrophy are
independent processes that synergistically affect memory decline.
These findings suggest that age-related memory decline is a heteroge-
neous condition in which different pathologies contribute to the
memory decline observed in elderly with SVD.
Major strengths of this study include the large number of partici-
pants with SVD included in the study and the longitudinal design of
our study with three neuroimaging assessments over 9 years, which
enabled us to study temporal interactions between WMH progres-
sion, hippocampal atrophy, and memory decline beyond cross-
sectional associations. Several methodological issues and limitations
deserve consideration. First, slight changes in neuroimaging protocols
between baseline and first follow-up might be a potential source of
bias. To minimize effects of changes in FLAIR sequence we resliced
follow-up FLAIR images to match the slice thickness of baseline
images using linear interpolation. Besides, we calculated WMH vol-
umes for odd and even slices separately to determine the effects of
change in slice thickness of the FLAIR sequence. This revealed similar
results. Furthermore, hippocampal volumes were calculated using sub-
ject templates as part of the longitudinal segmentation pipeline,
reducing the risk of bias in longitudinal volume calculations. Another
limitation might be that learning effects have led to an underestima-
tion of memory decline in our study population. We limited these pos-
sible learning effects by the use of alternative versions of the memory
tasks during the second follow-up assessment. Due to the long-term
follow-up of our study a proportion of the participants was unable to
complete the entire follow-up. This attrition bias might have led to an
underestimation of the effects, since those lost to follow-up had more
severe WMH, smaller hippocampal volumes and were cognitively
more impaired already at baseline. However, by mixed effects models
we could also take into account the participants with one or more
missing values, thereby limiting the effect of the attrition bias. Finally,
as we did not have pathological confirmations on cerebrovascular or
AD pathologies, we used WMH and hippocampal volumes as markers
of these two diseases.
In conclusion, memory decline in elderly with SVD was best
explained by the interaction of WMH with hippocampal atrophy. The
relationship between WMH and memory was not causally mediated
by hippocampal atrophy, suggesting that memory decline during aging
is a heterogeneous condition in which different pathologies contribute
to the memory decline observed in elderly patients with SVD.
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